The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. Although human papillomavirus (HPV) infection is considered as a favorable prognostic factor in oropharyngeal cancer, the prognosis of HPV-associated tonsil cancer has rarely been studied especially when surgery was the main treatment. In this study, the authors investigated the effect of p16 over-expression (HPV infection) on tonsil cancer prognosis according to the type of treatment, HPV presence by PCR, and expression of p53 and epidermal growth factor receptor (EGFR) by immunohistochemistry (IHC). Methods. Medical records of 33 tonsil cancer patients were reviewed. Using formalin-fixed and paraffin-embedded tumor specimens, PCR-based genotyping of HPV and IHC of p16, p53 and EGFR were performed. The effects of HPV presence and the expression of IHC markers were analyzed on the recurrence-free survival. Five-year disease-free survival (DFS) rates were evaluated according to p16 expression status. Results. An over-expression of p16 was observed in 27 (81.9%) out of 33 cases. Surgery-based treatment was provided for 21 (63.6%) patients. There was no association between p16 immunoreactivity and HPV presence, nor with p53 and EGFR expression. Regardless of main treatment modalities, five-year DFS did not differ by p16 expression status (P=0.051). However, over-expression of p16 was associated with a lower recurrence in multivariable analyses (P=0.046). Conclusion. Regardless of main treatment modalities, an over-expression of p16 (HPV infection) is associated with a lower recurrence in tonsil cancers. However it is not associated with simple HPV presence or p53 and EGFR over-expression.
Abstract
Objectives. Although human papillomavirus (HPV) infection is considered as a favorable prognostic factor in oropharyngeal cancer, the prognosis of HPV-associated tonsil cancer has rarely been studied especially when surgery was the main treatment. In this study, the authors investigated the effect of p16 over-expression (HPV infection) on tonsil cancer prognosis according to the type of treatment, HPV presence by PCR, and expression of p53 and epidermal growth factor receptor (EGFR) by immunohistochemistry (IHC). Methods. Medical records of 33 tonsil cancer patients were reviewed. Using formalin-fixed and paraffin-embedded tumor specimens, PCR-based genotyping of HPV and IHC of p16, p53 and EGFR were performed. The effects of HPV presence and the expression of IHC markers were analyzed on the recurrence-free survival. Five-year disease-free survival (DFS) rates were evaluated according to p16 expression status. Results. An over-expression of p16 was observed in 27 (81.9%) out of 33 cases. Surgery-based treatment was provided for 21 (63.6%) patients. There was no association between p16 immunoreactivity and HPV presence, nor with p53 and EGFR expression. Regardless of main treatment modalities, five-year DFS did not differ by p16 expression status (P=0.051). However, over-expression of p16 was associated with a lower recurrence in multivariable analyses (P=0.046). Conclusion. Regardless of main treatment modalities, an over-expression of p16 (HPV infection) is associated with a lower recurrence in tonsil cancers. However it is not associated with simple HPV presence or p53 and EGFR over-expression.
참고문헌 (16)
- Syrjanen K, "Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis", Int J Oral Surg, 12(6), pp.418~424 (1983)
- Ha PK, "The role of human papillomavirus in oral carcinogenesis", Crit Rev Oral Biol Med, 15(4), pp.188~196 (2004)
- Allen CT, "Human papillomavirus and oropharynx cancer: biology, detection and clinical implications", Laryngoscope, 120(9), pp.1756~1772 (2010)
- Reimers N, "Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer", Int J Cancer, 120(8), pp.1731~1738 (2007)
- Hafkamp HC, "Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas", Int J Cancer, 122(12), pp.2656~2664 (2008)
- "J Clin Oncol", 2009, 6003~
- Al-Swiahb JN, "Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area", Arch Otolaryngol Head Neck Surg, 136(5), pp.502~508 (2010)
- Ciardiello F, "A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor", Clin Cancer Res, 7(10), pp.2958~2970 (2001)
- Thomas J, "Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?", Ann Diagn Pathol, 16(2), pp.91~99 (2012)
- El-Naggar AK, "p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency", Head Neck, 34(4), pp.459~461 (2012)
- Chien CY, "The clinicopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngeal cancer", Cancer Lett, 201(2), pp.217~223 (2003)
- Li W, "New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis", Pathology, 39(2), pp.217~222 (2007)
- Ragin CC, "Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis", Int J Cancer, 121(8), pp.1813~1820 (2007)
- Smeets SJ, "A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen", Int J Cancer, 121(11), pp.2465~2472 (2007)
- Hafkamp HC, "A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16", 18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8, 2003, pp.107(3), 394~400
- Kumar B, "EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer", J Clin Oncol, 26(19), pp.3138~3137 (2008)